Share-Based Payment (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure of share-based payment arrangements [text block] [Abstract]

Schedule of number of share options and their related weighted average exercise prices

	Year ended December 31,
	2021					2020					2019
	Number of options			Weighted average exercise price (USD)		Number of options			Weighted average exercise price		Number of options		Weighted average exercise price
Outstanding at beginning of year		16,200,000			0.07		6,200,000			0.15		6,200,000		0.15
Granted		-			-		20,000,000			0.03		-		-
Exercised		-			-		-			-		-		-
Expired		(3,433,331	)		0.16		-			-		-		-
Forfeited		(366,669	)		0.08		(10,000,000	)		0.03		-		-
Outstanding at end of year		12,400,000			0.05		16,200,000			0.07		6,200,000		0.15
Exercisable at end of year		7,399,998			0.07		7,699,997			0.13		5,949,998		0.16

Schedule of exercise price and the remaining contractual life (in years)

December 31,
2021					2020
Options outstanding at end of year	Range of exercise prices (USD)		Weighted average remaining contractual life		Options outstanding at end of year		Range of exercise prices (USD)	Weighted average remaining contractual life
10,900,000		0.03 - 0.14		7.94		12,150,000	0 - 0.14		8.65
1,500,000		0.17		3.66		4,050,000	0.15 -1.6		4.12
12,400,000						16,200,000

December 31,
2019
Options outstanding at end of year		Range of exercise prices (USD)		Weighted average remaining contractual life
	2,150,000		0 - 0.14		6.24
	4,050,000		0.15 -1.6		5.12
	6,200,000

Schedule of outstanding options

Options  outstanding		Position	Grant date (*)	Exercise price in NIS		Fair value USD in thousands		Vesting schedule
	600,000	Four Directors	December 30, 2014		0.4325		46	33.33% of the stock options vest following the lapse of 12 months from the grant date, and the remaining 66.67% vest in 8 equal portions each quarter over a period of 2 years from the first
	300,000	Two Directors	March 25, 2015		0.40		24	33.33% of the stock options vest following the lapse of 12 months from the grant date, and the remaining 66.67% vest in 8 equal portions each quarter over a period of 2 years from the first
	1,500,000	Chairman of Board	March 31, 2016		0.6		63	12 equal portions each quarter over a period of 3 years from the date of grant
	10,000,000	Chief Executive Officer (new)	July 7, 2020		0.09		103	12 equal portions each quarter over a period of 3 years from the grant date
	12,400,000

(*) Date of the Company’s Board of Directors’ decision (or shareholders, if required).

(**) As of December 31, 2021, the unrecognized compensation cost related to all unvested options of approximately $15 thousands is expected to be recognized as an expense over a weighted-average recognition period of approximately 1.5 years.

Schedule of detailed information about the fair value for options granted

	2020
Dividend yield		0	%
Expected volatility		74.2	%
Risk-free interest		0.67	%
Expected life (years)		10